|
⚲
|
| Keyboard |
| Lapointe Anthony Gregg
✚
|
|
|---|---|
| CIK # | 0001331860 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001331860] | |
| 4 | [0001331860] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,100 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,100 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 8,333 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 16,666 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 26,550 | ||
|
Soligenix Inc SNGX
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 17,647 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2025-06-11 | Grant | 26,550 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2025-05-23 | Grant | 3,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Common Stock
|
2025-05-23 | Grant | 2,500 | $0.00 | |
|
Soligenix Inc SNGX
Stock Option (Right to Buy) · derivative
|
2024-12-12 | Grant | 8,646 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2024-06-05 | Grant | 14,100 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Common Stock
|
2024-05-25 | Grant | 25,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2024-05-25 | Grant | 30,000 | $0.00 | |
|
Soligenix Inc SNGX
Stock Option (Right to Buy) · derivative
|
2023-12-15 | Grant | 38,136 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2023-06-02 | Grant | 14,100 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Common Stock
|
2023-05-26 | Grant | 25,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2023-05-26 | Grant | 30,000 | $0.00 | |
|
Soligenix Inc SNGX
Stock Option (Right to Buy) · derivative
|
2022-11-17 | Grant | 46,154 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (right to buy) · derivative
|
2022-06-09 | Grant | 8,333 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2022-05-20 | Grant | 30,000 | $0.00 | |
| showing 20 of 68 most recent transactions | |||||